Eleni Giannoulatou

Dr. Eleni Giannoulatou

Computational Genomics Laboratory, Victor Chang Cardiac Research Institute, Darlinghurst, NSW 2010, Australia

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2010 in Nature
Verified
Journal Article
Open access
PDF file
WCWellcome Trust Case Control Consortium
Wellcome Trust Case Control Consortium
NCNick Craddock
Nick Craddock
MHMatthew E Hurles
Matthew E Hurles
NCNiall Cardin
Niall Cardin
RPRichard D Pearson
Richard D Pearson
PDPeter Donnelly
Peter Donnelly
Copy number variants (CNVs) account for a major proportion of human genetic polymorphism and have been predicted to have an important role in genetic susceptibility to common disease. To address this we undertook a large, direct genome-wide study of association between CNVs and eight common human diseases. Using a purpose-designed array we typed ∼19,000 individuals into distinct copy-number classes at 3,432 polymorphic CNVs, including an estimated ∼50% of all common CNVs larger than 500 base pairs. We identified several biological artefacts that lead to false-positive associations, including systematic CNV differences between DNAs derived from blood and cell lines. Association testing and follow-up replication analyses confirmed three loci where CNVs were associated with disease—IRGM for Crohn’s disease, HLA for Crohn’s disease, rheumatoid arthritis and type 1 diabetes, and TSPAN8 for type 2 diabetes—although in each case the locus had previously been identified in single nucleotide polymorphism (SNP)-based studies, reflecting our observation that most common CNVs that are well-typed on our array are well tagged by SNPs and so have been indirectly explored through SNP studies. We conclude that common CNVs that can be typed on existing platforms are unlikely to contribute greatly to the genetic basis of common human diseases.

12 January 2014 in Nature Genetics
Verified
Journal Article
Closed access
JHJim R Hughes
Jim R Hughes
NRNigel Roberts
Nigel Roberts
SMSimon McGowan
Simon McGowan
DHDeborah Hay
Deborah Hay
Eleni GiannoulatouEleni Giannoulatou
Eleni Giannoulatou
DHDouglas R Higgs
Douglas R Higgs

8 June 2017 in Nature Reviews Cardiology
Verified
Journal Article
Closed access
ELEdmund M. T. Lau
Edmund M. T. Lau
Eleni GiannoulatouEleni Giannoulatou
Eleni Giannoulatou
DCDavid S. Celermajer
David S. Celermajer
MHMarc Humbert
Marc Humbert

1 June 2014 in Cancer Cell
Verified
Journal Article
Closed access
PWPetter S. Woll
Petter S. Woll
UKUna Kjällquist
Una Kjällquist
OCOnima Chowdhury
Onima Chowdhury
HDHelen Doolittle
Helen Doolittle
DWDavid Wedge
David Wedge
SJSten Eirik W. Jacobsen
Sten Eirik W. Jacobsen

29 January 2013 in Nature Communications
Verified
Journal Article
Open access
YZYong-Hong Zhang
Yong-Hong Zhang
YZYan Zhao
Yan Zhao
NLNing Li
Ning Li
YPYan-Chun Peng
Yan-Chun Peng
Eleni GiannoulatouEleni Giannoulatou
Eleni Giannoulatou
TDTao Dong
Tao Dong
The SNP rs12252-C allele alters the function of interferon-induced transmembrane protein-3 increasing the disease severity of influenza virus infection in Caucasians, but the allele is rare. However, rs12252-C is much more common in Han Chinese. Here we report that the CC genotype is found in 69% of Chinese patients with severe pandemic influenza A H1N1/09 virus infection compared with 25% in those with mild infection. Specifically, the CC genotype was estimated to confer a sixfold greater risk for severe infection than the CT and TT genotypes. More importantly, because the risk genotype occurs with such a high frequency, its effect translates to a large population-attributable risk of 54.3% for severe infection in the Chinese population studied compared with 5.4% in Northern Europeans. Interferon-induced transmembrane protein-3 genetic variants could, therefore, have a strong effect of the epidemiology of influenza in China and in people of Chinese descent.

10 August 2017 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
HSHongjun Shi
Hongjun Shi
AEAnnabelle Enriquez
Annabelle Enriquez
MRMelissa Rapadas
Melissa Rapadas
EMElla M.M.A. Martin
Ella M.M.A. Martin
RWRoni Wang
Roni Wang
SDSally Dunwoodie
Sally Dunwoodie
Congenital malformations can be manifested as combinations of phenotypes that co-occur more often than expected by chance. In many such cases, it has proved difficult to identify a genetic cause. We sought the genetic cause of cardiac, vertebral, and renal defects, among others, in unrelated patients. We used genomic sequencing to identify potentially pathogenic gene variants in families in which a person had multiple congenital malformations. We tested the function of the variant by using assays of in vitro enzyme activity and by quantifying metabolites in patient plasma. We engineered mouse models with similar variants using the CRISPR (clustered regularly interspaced short palindromic repeats)–Cas9 system. Variants were identified in two genes that encode enzymes of the kynurenine pathway, 3-hydroxyanthranilic acid 3,4-dioxygenase (HAAO) and kynureninase (KYNU). Three patients carried homozygous variants predicting loss-of-function changes in the HAAO or KYNU proteins (HAAO p.D162*, HAAO p.W186*, or KYNU p.V57Efs*21). Another patient carried heterozygous KYNU variants (p.Y156* and p.F349Kfs*4). The mutant enzymes had greatly reduced activity in vitro. Nicotinamide adenine dinucleotide (NAD) is synthesized de novo from tryptophan through the kynurenine pathway. The patients had reduced levels of circulating NAD. Defects similar to those in the patients developed in the embryos of Haao-null or Kynu-null mice owing to NAD deficiency. In null mice, the prevention of NAD deficiency during gestation averted defects. Disruption of NAD synthesis caused a deficiency of NAD and congenital malformations in humans and mice. Niacin supplementation during gestation prevented the malformations in mice. (Funded by the National Health and Medical Research Council of Australia and others.)